文献速递免疫规划传染病防控与疫情报告

基于健康保险理赔数据评估德国2006至2015年水痘疫苗效果及其影响因素

Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015.
PubMed 文献 · Euro Surveill · 2017-01-01

德国2004年实施儿童常规水痘疫苗接种,2009年起推荐两剂次。未接种儿童在低接种率地区感染风险高两倍。

要点

  • 一剂水痘疫苗VE为81.9%(95%CI:81.4-82.5),两剂VE为94.4%(95%CI:94.2-94.6)。
  • 首剂在含麻疹成分疫苗后1-27天接种时,一剂VE为32.2%(95%CI:10.4-48.6)。
  • 未接种儿童在低接种率地区感染水痘风险是高接种率地区的两倍。

核心结论

  • 两剂水痘疫苗接种至少8年提供良好保护,未接种儿童受益于群体效应。
  • 当第一剂水痘疫苗在含麻疹成分疫苗后短期接种时,第二剂至关重要。

研究设计与样本

  • 研究利用基于全国健康保险理赔数据的免疫信息体系,采用比例风险模型估计不同条件下的疫苗效果。

主要发现

  • 一剂水痘疫苗VE为81.9%(95%CI:81.4-82.5),两剂VE为94.4%(95%CI:94.2-94.6)。
  • 首剂在含麻疹成分疫苗后1-27天接种时,一剂VE为32.2%(95%CI:10.4-48.6),两剂VE为92.8%(95%CI:84.8-96.6)。
  • VE与接种年龄(11-14月龄 vs ≥15月龄)、接种后时间或疫苗类型无关。
  • 未接种儿童在低接种率地区感染水痘风险是高接种率地区的两倍。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In Germany, routine childhood varicella vaccination was implemented in 2004 with two doses recommended since 2009. We used an immunisation information system based on countrywide health insurance claims data to analyse vaccine effectiveness (VE) and factors influencing VE. We applied proportional hazard models to estimate VE under various conditions and compared the risk of acquiring varicella among unvaccinated children in regions with high vs low vaccination coverage (VC). Among 1.4 million children we identified 29,404 varicella cases over a maximum follow-up of 8 years post-vaccination. One-dose VE was 81.9% (95% confidence interval (CI): 81.4-82.5), two-dose VE 94.4% (95% CI: 94.2-94.6). With dose one given 1-27 days after measles-containing vaccine (MCV), one-dose VE was 32.2% (95% CI: 10.4-48.6), two-dose VE 92.8% (95% CI: 84.8-96.6). VE was not associated with age at vaccination (11-14 vs ≥ 15 months), time since vaccination, or vaccine type. Unvaccinated children had a twofold higher risk of acquiring varicella in low VC regions. Our system generated valuable data, showing that two-dose varicella vaccination provides good protection for at least 8 years. Unvaccinated children benefit from herd effects. When the first varicella vaccine dose is given shortly after MCV, a second dose is essential.

来源:Euro Surveill,查看原文。版权归原作者所有。

引用

  1. Rieck T, Feig M, An der Heiden M, et al. Assessing varicella vaccine effectiveness and its influencing factors using health insurance claims data, Germany, 2006 to 2015. Euro Surveill. 2017. PMID: 28488996. doi:10.2807/1560-7917.ES.2017.22.17.30521

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。